文献速递关节外科创伤骨科

重复两阶段翻修关节置换术治疗假体周围膝关节感染取决于宿主分级

Repeat Two-Stage Exchange Arthroplasty for Periprosthetic Knee Infection Is Dependent on Host Grade.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

本研究回顾性分析2000至2013年间45例因假体周围膝关节感染接受两次或以上两阶段翻修关节置换术的患者,按MSIS系统分层并分析失败危险因素,平均随访6年。结果显示无免疫受损宿主(MSIS A型)伴可接受伤口(1或2型)成功率70%(7/10),B2型宿主成功率50%(10/20),而C3型宿主均失败。

要点

  • 无免疫受损宿主(MSIS A型)伴可接受伤口(MSIS 1或2型)重复两阶段翻修成功率70%(7/10)。
  • MSIS B2型宿主重复两阶段翻修成功率50%(10/20)。
  • MSIS C3型宿主重复两阶段翻修均失败,作者认为应考虑替代挽救手术。

核心结论

  • 无免疫受损宿主(MSIS A型)伴可接受伤口(MSIS 1或2型)重复两阶段翻修关节置换术后成功率为70%(7/10)。
  • MSIS B2型宿主成功率为50%(10/20)。
  • MSIS C3型宿主重复两阶段翻修均失败,作者认为对此类患者应考虑替代挽救手术。

研究设计与样本

  • 回顾性识别2000至2013年间45例因假体周围膝关节感染接受2次或以上两阶段翻修关节置换术的患者。
  • 按MSIS系统对患者进行分层,并分析失败的危险因素。
  • 最低随访2年(平均6年;范围24至132个月)。

主要发现

  • 随访时,22例(49%)患者因感染再次接受翻修,28例(62%)患者因任何原因再次接受翻修。
  • 第二次两阶段翻修关节置换术后,8例严重免疫受损宿主(MSIS C型)中6例(75%)感染复发,10例无免疫受损宿主(A型)中3例(30%)感染复发(p=0.06)。
  • 5例肢体受损患者(MSIS 3型)中4例(80%)感染复发,9例肢体未受损患者(1型)中3例(33%)感染复发(p=0.27)。
  • 2例宿主和肢体均严重受损(C3型)的患者均感染复发,而10例无或较少肢体受损的无免疫受损患者(A1或A2型)中3例(30%)感染复发。
  • 失败组中5例患者在再感染后接受第三次两阶段翻修关节置换术,其中3例在末次随访时无感染。

关键数值与推荐

  • 无免疫受损宿主(MSIS A型)伴可接受伤口(MSIS 1或2型)重复两阶段翻修关节置换术后成功率为70%(7/10)。
  • MSIS B2型宿主成功率为50%(10/20)。
  • MSIS C3型宿主重复两阶段翻修均失败。

临床怎么用

  • 作者认为,对于MSIS C3型宿主,应考虑替代挽救手术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two-stage exchange arthroplasty after a previous, failed 2-stage exchange procedure is fraught with difficulties, and there are no clear guidelines for treatment or prognosis given the heterogeneous group of patients in whom this procedure has been performed. The Musculoskeletal Infection Society (MSIS) staging system was developed in an attempt to stratify patients according to infection type, host status, and local soft-tissue status. The purpose of this study was to report the results of 2-stage exchange arthroplasty following a previous, failed 2-stage exchange protocol for periprosthetic knee infection as well as to identify risk factors for failure. METHODS: We retrospectively identified 45 patients who had undergone 2 or more 2-stage exchange arthroplasties for periprosthetic knee infection from 2000 to 2013. Patients were stratified according to the MSIS system, and risk factors for failure were analyzed. The minimum follow-up was 2 years (mean, 6 years; range, 24 to 132 months). RESULTS: At the time of follow-up, twenty-two (49%) of the patients had undergone another revision due to infection and 28 (62%) had undergone another revision for any reason. The infection recurred in 6 (75%) of 8 substantially immunocompromised hosts (MSIS type C) and in 3 (30%) of 10 uncompromised hosts (type A) following the second 2-stage exchange arthroplasty (p = 0.06). The infection recurred in 4 (80%) of 5 patients with compromise of the extremity (MSIS type 3) and 3 (33%) of 9 patients with an uncompromised extremity (type 1) (p = 0.27). Both extremely compromised hosts with an extremely compromised extremity (type C3) had recurrence of the infection whereas 3 (30%) of the 10 uncompromised patients with no or less compromise of the extremity (type A1 or A2) did. Five patients in the failure group underwent a third 2-stage exchange arthroplasty following reinfection, and 3 of them were infection-free at the time of the latest follow-up. CONCLUSIONS: Uncompromised hosts (MSIS type A) with an acceptable wound (MSIS type 1 or 2) had a 70% rate of success (7 of 10) after a repeat 2-stage exchange arthroplasty, whereas type-B2 hosts had a 50% success rate (10 of 20). The repeat 2-stage exchange procedure failed in both type-C3 hosts; thus, alternative salvage procedures should be considered for such patients. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Fehring KA, Abdel MP, Ollivier M, et al. Repeat Two-Stage Exchange Arthroplasty for Periprosthetic Knee Infection Is Dependent on Host Grade. J Bone Joint Surg Am. 2017. PMID: 28060229. doi:10.2106/JBJS.16.00075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。